Physician profile
Kumar Sambhav
NPI 1790216729
$994.93
in general payments reported to CMS, 2019-2025
7 companies · $315 in 2025
The $315 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.10 · 2021: $13.16 · 2022: $48.49 · 2023: $337 · 2024: $192 · 2025: $315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $600 · Travel and Lodging: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.77 |
| Travel and Lodging | $244.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $560.12 | 2021-2025 | Clareon, Voyager Dslt, Unity |
| Dutch Ophthalmic, USA | $211.87 | 2023-2024 | Tissueblue, Eva, Combined Machine |
| Regeneron Healthcare Solutions, INC. | $89.10 | 2019 | |
| Merz Pharmaceuticals, LLC | $80.98 | 2023 | Xeomin |
| Genentech, INC. | $19.30 | 2023 | Vabysmo, Susvimo |
| Bausch & Lomb Americas INC. | $17.10 | 2022 | |
| Alimera Sciences, INC. | $16.46 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kumar Sambhav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.